A paradigm shift in the medical treatment of acromegaly: from a "trial and error' to a personalized therapeutic decision-making process

被引：20
作者：
Gadelha, Monica R. [1 ,2 ]
机构：
[1] Univ Fed Rio de Janeiro, Neuroendocrinol Res Ctr, Endocrine Sect, Sch Med, BR-21941913 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941913 Rio De Janeiro, Brazil
来源：
CLINICAL ENDOCRINOLOGY | 2015年 / 83卷 / 01期
关键词：
SOMATOSTATIN ANALOGS; BIOCHEMICAL RESPONSE; CLINICAL-PRACTICE; SURGERY; SOMATOTROPINOMAS; GUIDELINES; EXPRESSION; MORTALITY; PREDICTS;
D O I：
10.1111/cen.12797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 15 条
[1]   Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial [J].
Caron, Philippe J. ;
Bevan, John S. ;
Petersenn, Stephan ;
Flanagan, Daniel ;
Tabarin, Antoine ;
Prevost, Gaetan ;
Maisonobe, Pascal ;
Clermont, Antoine .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (04) :1282-1290
[2]   Systemic complications of acromegaly: Epidemiology, pathogenesis, and management [J].
Colao, A ;
Ferone, D ;
Marzullo, P ;
Lombardi, G .
ENDOCRINE REVIEWS, 2004, 25 (01) :102-152
[3]   Novel pathway for somatostatin analogs in patients with acromegaly [J].
Gadelha, Monica R. ;
Kasuki, Leandro ;
Korbonits, Marta .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2013, 24 (05) :238-246
[4]   Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly [J].
Gatto, Federico ;
Feelders, Richard A. ;
van der Pas, Rob ;
Kros, Johan M. ;
Waaijers, Marlijn ;
Sprij-Mooij, Diana ;
Neggers, Sebastian J. C. M. M. ;
van der Lelij, Aart-Jan ;
Minuto, Francesco ;
Lamberts, Steven W. J. ;
de Herder, Wouter W. ;
Ferone, Diego ;
Hofland, Leo J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (01) :E66-E71
[5]   Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly [J].
Giustina, Andrea ;
Mazziotti, Gherardo ;
Torri, Valter ;
Spinello, Maurizio ;
Floriani, Irene ;
Melmed, Shlomo .
PLOS ONE, 2012, 7 (05)
[6]   A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly [J].
Holdaway, I. M. ;
Bolland, M. J. ;
Gamble, G. D. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 (02) :89-95
[7]   Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long? [J].
Jacob, Jubbin J. ;
Bevan, John S. .
CLINICAL ENDOCRINOLOGY, 2014, 81 (06) :812-817
[8]   AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression [J].
Kasuki, Leandro ;
Vieira Neto, Leonardo ;
Wildemberg, Luiz Eduardo A. ;
Colli, Leandro Machado ;
de Castro, Margaret ;
Takiya, Christina M. ;
Gadelha, Monica R. .
ENDOCRINE-RELATED CANCER, 2012, 19 (03) :L25-L29
[9]   Acromegaly: An Endocrine Society Clinical Practice Guideline [J].
Katznelson, Laurence ;
Laws, Edward R., Jr. ;
Melmed, Shlomo ;
Molitch, Mark E. ;
Murad, Mohammad Hassan ;
Utz, Andrea ;
Wass, John A. H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (11) :3933-3951
[10]  
Katznelson L, 2011, ENDOCR PRACT, V17, P1
12